Kelly Walker
Medical · Oklahoma City, OKNPI 1801293105
Payments from drug & device makers
Across 113 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$527
- Pfizer$497
- Amgen$207
- Merck$181
- Actelion Pharmaceuticals US, Inc.$178
- Johnson & Johnson$146
- plus $673 from 17 others
What the payments were for
- Food & beverage$2,409100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $527 |
| Pfizer | 21 | $497 |
| Amgen | 11 | $207 |
| Merck | 9 | $181 |
| Actelion Pharmaceuticals US, Inc. | 8 | $178 |
| Johnson & Johnson(2 entities) | 8 | $146 |
| Abbott | 5 | $137 |
| E.r. Squibb & Sons, L.L.C. | 4 | $82 |
| Boehringer Ingelheim | 4 | $76 |
| AstraZeneca | 4 | $60 |
| Novartis | 3 | $59 |
| Atricure, Inc. | 1 | $44 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Kestra Medical Technology Services, Inc. | 2 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Medtronic | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Novo Nordisk | 1 | $14 |
| Chiesi USA, Inc. | 1 | $14 |
| Surmodics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$125
How this compares
$2,409 in reported general payments places this provider in the 80th percentile of 370 medical providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 15 | $219 |
| Atorvastatin Calcium | 15 | $128 |
| ClopidogrelClopidogrel Bisulfate | 12 | $104 |
Paid to pharmacies, not to this prescriber.
Other medical in Oklahoma City
- Mebin ThomasOklahoma City$323K
- Kristine MurrowOklahoma City$81K
- Katelyn PuryearOklahoma City$22K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
- Vy TranOklahoma City$15K
- Jennifer MinshallOklahoma City$11K
- Lindee LedbetterOklahoma City$10K
- Christina HelmsOklahoma City$7K
- John ParmeleeOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.